Welcome to Hobson Prior

Hobson Prior is an award-winning staffing services business focused on the global life sciences industry.

We specialise in the source and supply of mid to upper level clinical, medical and regulatory specialists involved in drug discovery, clinical development and post-approval processes.

Please click here to view our client brochure

 

Clients

Click here for more information about us, our services and our global compliance commitment.

Candidates

Click here for information on contracting in the UK, Switzerland and Internationally, and access to our contractor portal.

Candidates Login

Vacancy Search

Quick job search

Advanced Search

Latest News

GSK's shingle vaccine hits efficacy targets

GSK's shingle vaccine hits efficacy targets

AZ' first-in-class PARP inhibitor Lynparza wins EU nod

AZ' first-in-class PARP inhibitor Lynparza wins EU nod

Merck buys OncoEthix for $375m

Merck buys OncoEthix for $375m

Study identifies 53 approved drugs that may block Ebola

Study identifies 53 approved drugs that may block Ebola

Right pathway, wrong drug? Roche's pictilisib trips up

Right pathway, wrong drug? Roche's pictilisib trips up

Data shows immunotherapy promise in breast cancer

Data shows immunotherapy promise in breast cancer

Bayer loses bid to overturn India's first compulsory licence

Bayer loses bid to overturn India's first compulsory licence

First blood treatment system in US could cut cost of transfusions

It is difficult to say how much of a role panic over this summer’s Ebola outbreak played in the FDA’s decision to approve Cerus’s blood filtration system, but it seems likely to have...

Upcoming events: Roche PD-L1 data and FDA decisions for AbbVie and Actavis

Welcome to your weekly digest of approaching regulatory and clinical readouts. AbbVie is to receive a US decision imminently on its all oral, interferon-free, hep C combo; the company's US...

Stevenage to get £55m cell therapy facility

Stevenage to get £55m cell therapy facility
more news